SCHEDULE: Mangoceuticals CEO Boosts Stake, Secures Related-Party Financing

Mangoceuticals, Inc. CEO Jacob D. Cohen increased his beneficial ownership to 14.6% through new stock and option grants, while the company secured a convertible loan and warrants from his controlled trust.

Summary

• Jacob D. Cohen and The Tiger Cub Trust (controlled by Cohen) filed an Amendment No. 5 to their Schedule 13D, detailing recent transactions and beneficial ownership changes.
• The company executed a 1-for-15 reverse stock split effective October 16, 2024, which is reflected in current disclosures.
• On June 5, 2025, Mr. Cohen gifted 200,000 shares of common stock he held personally to The Tiger Cub Trust for no consideration.
• On May 2, 2025, Mangoceuticals borrowed $100,000 from The Tiger Cub Trust, evidenced by a Promissory Note bearing an 18% annual interest rate.
• Effective July 21, 2025, the Promissory Note was amended and restated into a Convertible Promissory Note (A&R Note), providing The Tiger Cub Trust the option to convert principal and accrued interest into common stock at $1.785 per share and removing the mandatory prepayment requirement.
• Concurrently on July 21, 2025, the company granted The Tiger Cub Trust warrants to purchase 50,000 shares of common stock (Tiger Cub Warrants) at an exercise price of $1.815 per share, with a term through July 21, 2028.
• Effective September 9, 2025, Jacob D. Cohen, as CEO, was granted 500,000 shares of common stock as a bonus for services rendered in 2025.
• Additionally, on September 9, 2025, Mr. Cohen was granted options to purchase 2,000,000 shares of common stock at an exercise price of $2.30 per share, vesting over 18 months (500,000 upon grant, and 500,000 on the 6th, 12th, and 18th month anniversaries).
• As of September 11, 2025, Jacob D. Cohen beneficially owns 2,044,356 shares, representing 14.6% of the class, and The Tiger Cub Trust beneficially owns 911,023 shares, representing 6.8% of the class, based on 13,266,437 shares outstanding.

Sentiment

Score: 5

Explanation: The filing presents a mixed bag. While it shows continued commitment from the CEO and secures some financing, the high interest rate on the loan and significant potential dilution from equity grants and convertible instruments are notable concerns. The related-party nature of the transactions also introduces governance considerations.

Positives

• CEO Jacob D. Cohen demonstrates increased commitment and alignment with shareholders through significant stock and option grants.
• The company secured $100,000 in financing, providing capital for operations.
• The conversion feature of the A&R Note offers the company flexibility by potentially converting debt to equity.
• The removal of the mandatory prepayment requirement for the A&R Note provides the company with greater financial flexibility.

Negatives

• The $100,000 loan from The Tiger Cub Trust carries a high annual interest rate of 18%, indicating potentially challenging financing conditions for the company.
• The significant grants of 500,000 shares and options for 2,000,000 shares to the CEO, along with the convertible note and warrants, represent substantial potential dilution for existing shareholders.
• The transactions involve related parties (CEO and his controlled trust), raising potential corporate governance concerns regarding conflicts of interest.

Risks

• Dilution Risk: The issuance of 500,000 shares, 2,000,000 options, 56,023 shares from the A&R Note conversion, and 50,000 shares from Tiger Cub Warrants could significantly dilute the ownership percentage of existing shareholders.
• Related Party Transaction Risk: The company's reliance on financing from a trust controlled by its CEO introduces potential conflicts of interest and may not represent arm's-length terms.
• High Cost of Capital: The 18% interest rate on the promissory note indicates a high cost of capital, which could strain the company's financial resources if not managed effectively.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the vesting schedule of options and maturity dates of financial instruments.

Management Comments

• The 500,000 shares of common stock granted to Jacob D. Cohen were a bonus in consideration for services rendered to the Company as Chief Executive Officer during 2025.

Industry Context

This filing primarily details changes in beneficial ownership and related-party financing, which are internal company matters. It does not provide sufficient information to analyze broader industry trends or competitive positioning.

Comparison to Industry Standards

• NA

Corporate Governance

Related Party Transactions

• Jacob D. Cohen gifted 200,000 shares of common stock to The Tiger Cub Trust, an entity he controls, for no consideration.
• The company borrowed $100,000 from The Tiger Cub Trust, controlled by CEO Jacob D. Cohen, evidenced by a Promissory Note with an 18% interest rate.
• The Promissory Note was amended and restated into a Convertible Promissory Note (A&R Note) with The Tiger Cub Trust, allowing conversion into common stock at $1.785 per share.
• The company granted Tiger Cub Warrants to The Tiger Cub Trust to purchase 50,000 shares at an exercise price of $1.815 per share.
• The company granted 500,000 shares and options for 2,000,000 shares to Jacob D. Cohen, the CEO and Chairman.

Stakeholder Impact

• Shareholders: Potential for significant dilution from the issuance of new shares, options, convertible notes, and warrants. The related-party nature of transactions may raise concerns about fairness and transparency.
• Creditors: The conversion feature of the A&R Note could reduce the company's debt burden if exercised, but the high interest rate on the initial loan indicates higher risk.
• Management (Jacob D. Cohen): Substantially increased beneficial ownership and potential future equity, aligning his interests with the company's performance.

Next Steps

• Continued service of Mr. Cohen with the company for options to vest on 6th, 12th, and 18th month anniversaries of the grant date (September 9, 2025).
• Potential conversion of the A&R Note into common stock by The Tiger Cub Trust.
• Potential exercise of the Tiger Cub Warrants by The Tiger Cub Trust.
• Maturity of the A&R Note on May 2, 2026, if not converted earlier.

Key Dates

Recommendation

The filing reveals significant related-party transactions, including a high-interest loan and substantial equity grants to the CEO, which introduce potential dilution and governance concerns. While the CEO's increased stake shows commitment, the terms of the financing and the scale of potential dilution warrant caution. Without further operational or financial performance details, a 'hold' recommendation is appropriate, suggesting investors maintain their current position while monitoring future developments and the impact of these transactions.

Keywords

Mangoceuticals, Jacob D. Cohen, Tiger Cub Trust, Schedule 13D, beneficial ownership, stock split, convertible note, promissory note, stock options, warrants, CEO compensation, related party transaction, equity plan, dilution